The Analgesics Market was esteemed at USD 29.44 billion out of 2022 and is expected to arrive at USD 48 billion by 2030, and develop at a CAGR of 6.3% over the conjecture period 2023-2030.
Analgesics, often known as painkillers, are medications that are used to treat and alleviate pain. They're utilized when a patient's discomfort is overwhelming. The most often used topical analgesics worldwide are non-opioids, opioids, and compound analgesics (a combination of opioids and non-opioids). The most powerful painkillers are opioid medicines, which are made from opium. They're only provided with a prescription and are typically used to treat moderate to severe pain. Non-opioid drugs, on the other hand, contain acetaminophen rather than opium. NSAIDs (non-steroidal anti-inflammatory medicines) are another form of pain reliever.
Get more information on Analgesics Market - Request Sample Report
In a variety of clinical contexts for mild to severe acute and chronic pain, they are fast being advocated as a desirable, safe, and effective first-line treatment alternative to opioid medications. Prescribed analgesics, over-the-counter analgesics, and oral, intravenous, rectal, transdermal, and topical analgesics are among the several types of medications.
Pain from physiological injuries, operations, phantom aches, inflammation, neuropathic diseases, and cancer treatments are all treated with analgesics. With increasing internet penetration, several e-commerce platforms are now collaborating with pharmaceutical firms to deliver pharmaceuticals such as analgesics to consumers' homes.
DRIVERS
Increased Cases of Cardiovascular Disease, Cancer, and Arthritis
Increased Geriatric Population
Healthcare Initiatives by the Government
Advancement in treatment
The availability of well-known healthcare facilities
RESTRAINTS
Opioid abuse is illegal.
In emerging nations, the medical services area is growing.
OPPORTUNITIES
Research and development spending is increasing.
CHALLENGES
Analgesic Drugs' Side Effects
The COVID-19 epidemic had an influence on the global analgesics industry. The epidemic benefited the market because heightened attention to personal health boosted the purchasing of these treatments. COVID-19 was expected to increase demand for over-the-counter cold and cough treatments, as well as nutritional supplements, which were already in high demand. Moreover, the European Medicines Agency recommends using non-steroidal anti-inflammatories (NSAIDs) such ibuprofen and paracetamol at the lowest possible dose possible to treat moderate COVID-19 symptoms. Furthermore, because geriatrics are more susceptible to infection due to weakened immune systems and the lack of a vaccine or treatment, the number of older people infected with COVID-19 was high. As a result, during the epidemic, all of these causes raised the need for analgesics.
By Type:
Due to the widespread use of non-opioid analgesics for pain relief, as well as lower adverse effects and government and private-sector initiatives to promote the use of non-opioids drugs as a painkiller, the non-opioids drugs segment was the leading contributor in 2021 and is expected to remain so throughout the forecast period. Because opioids contain analgesic, anti-inflammatory, and antipyretic properties, the opioids medications segment is predicted to develop significantly during the forecast period. In addition, the opioid segment is predicted to develop due to an increase in the incidence of chronic diseases like tuberculosis (TB), cardiovascular disease, arthritis, and cancer over the forecast period.
By Route of Administration Type:
Due to the simple administration of analgesics by oral route, which is non-invasive in nature and effective when compared to other routes of administration, the oral administration segment dominated the market in 2020, and this pattern is supposed to go on during the anagesics market gauge period. Furthermore, the expansion of the oral administration segment is fueled by an increase in the number of FDA drug approvals in the United States and developments in pharmaceutical R&D activities. However, due to advancements in healthcare technology and an increase in the number of analgesics medications, the topical administration segment is likely to develop significantly throughout the projection period. Topical analgesics are applied to the skin over sore muscles or joints and massaged or sprayed on.
By Application type
Internal analgesics currently hold a significant market share. They are meant for internal usage and are either swallowed as pills or liquids, or put into the rectum as suppositories.
By Pain Type
Musculoskeletal pain currently accounts for the majority of the global market. An injury to the bones, joints, muscles, tendons, ligaments, or nerves is the most common cause.
By Drug type
Opioids are the most popular drugs on the market because they are commonly used to treat cancer pain and end-stage diseases that necessitate palliative care.
By Type
Opioids
Non-opioids
By Drug type
NSAID
Opioids
Others
By Route of Administration type
Oral
Topical
Transdermal
Parenteral
Rectal
By Pain Type
Musculoskeletal
Migraine
Neuropathic
Obstetrical
Surgical and Trauma
Cancer
Fibromyalgia
Pain due to Burns
By Application type
External
Internal
.png)
Need any customization research on Analgesics Market - Enquiry Now
Due to an increase in demand for non-opioids medications, the presence of important players, and the expansion of R&D activities in the healthcare sector in the area, North America dominated the analgesics market in 2020 and is likely to continue to do so during the forecast period. However, from 2022 to 2028, Asia-Pacific is expected to have the highest CAGR of 6.3%, owing to an increase in painkiller use, increased awareness about the use of analgesics drugs, increased healthcare expenditures, increased OTC analgesics market growth, and increased analgesics product adoption.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
South Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Some of the major key players are as follows: Johnson and johnson, Abbott Laboratories, Eli Lilly and Company, Bayer AG, endo pharmaceuticals, AbbVie Inc., Pfizer, Inc., GlaxoSmithKline plc, Sanofi, Reckitt Benckiser Group, and other players.
| Report Attributes | Details |
|---|---|
| Market Size in 2022 | US$ 29.44 Billion |
| Market Size by 2030 | US$ 48 Billion |
| CAGR | CAGR of 6.3% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Opioids, Non opioids), By Drug type (NSAID, Opioids, Others) • By Route of Administration type (Oral, Topical, Transdermal, Parenteral, Rectal) • By Pain Type (Musculoskeletal, Migraine, Neuropathic, Obstetrical, Surgical and Trauma, Cancer, Fibromyalgia, Pain due to Burns) • By Application (External, Internal) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | johnson and johnson, Abbott Laboratories, Eli Lilly and Company, Bayer AG, endo pharmaceuticals, AbbVie Inc., Pfizer, Inc., Glaxosmithkline plc, Sanofi, Reckitt Benckiser Group, and other players. |
| DRIVERS | • Increased Cases of Cardiovascular Disease, Cancer, and Arthritis • Increased Geriatric Population • Healthcare Initiatives by the Government |
| RESTRAINTS | • Opioid abuse is illegal. • In emerging nations, the medical services area is growing. |
Ans: - The Analgesics Market size is estimated to reach US$ 48 bn by 2030.
Analgesics Market is divided into four segments and they are By Type, By Drug type, By Route of Administration type, By Pain Type, and By Application type.
North America dominated the analgesics market.
Manufacturer and service provider, research institutes, university and private libraries, suppliers and distributers.
Ans: - The Analgesics market is expected to grow at a CAGR of 6.3% over the forecast period 2023-2030.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces Model
7. PEST Analysis
8. Analgesics Market Segmentation, By Type
8.1 Opioids
8.2 Non opioids
9. Analgesics Market Segmentation, By Drug type
9.1 NSAID
9.2 Opioids
9.3 Others
10. Analgesics Market Segmentation, By Route of Administration type
10.1 Oral
10.2 Topical
10.3 Transdermal
10.4 Parenteral
10.5Rectal
11. Analgesics Market Segmentation, By Pain Type
11.1 Musculoskeletal
11.2 Migraine
11.3 Neuropathic
11.4 Obstetrical
11.5 Surgical and Trauma
11.6 Cancer
11.7 Fibromyalgia
11.8 Pain due to Burns
12. Analgesics Market Segmentation, By Application type
12.1 External
12.2 Internal
13. Regional Analysis
13.1 Introduction
13.2 North America
13.2.1 USA
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 Germany
13.3.2 UK
13.3.3 France
13.3.4 Italy
13.3.5 Spain
13.3.6 The Netherlands
13.3.7 Rest of Europe
13.4 Asia-Pacific
13.4.1 Japan
13.4.2 South Korea
13.4.3 China
13.4.4 India
13.4.5 Australia
13.4.6 Rest of Asia-Pacific
13.5 The Middle East & Africa
13.5.1 Israel
13.5.2 UAE
13.5.3 South Africa
13.5.4 Rest
13.6 Latin America
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of Latin America
14. Company Profiles
14.1 johnson and johnson md&d.
14.1.1 Financial
14.1.2 Products/ Services Offered
14.1.3 SWOT Analysis
14.1.4 The SNS view
14.2 Abbott Laboratories
14.3 Eli Lilly and Company
14.4 Bayer AG
14.5 endo pharmaceuticals
14.6 AbbVie Inc.
14.7 Pfizer, Inc.
14.8 Glaxosmithkline plc
14.9 Sanofi
14.10 Reckitt Benckiser Group.
15. Competitive Landscape
15.1 Competitive Benchmarking
15.2 Market Share Analysis
15.3 Recent Developments
16. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Oligonucleotide Synthesis Market size was estimated at USD 7.8 billion in 2022 and is expected to reach USD 27.5 billion by 2030 at a CAGR of 17.1% during the forecast period of 2023-2030.
The Bone Densitometer Market Size was valued at USD 314.1 million in 2023 and is expected to reach USD 453.5 million by 2031 and grow at a CAGR of 4.7% over the forecast period 2024-2031.
The Cancer Registry Software Market Size was valued at USD 75.45 billion in 2022, and is expected to reach USD 171.39 billion by 2030 and grow at a CAGR of 10.8% over the forecast period 2023-2030.
The Clinical Decision Support Systems Market Size was valued at USD 5.08 billion in 2022 and is expected to reach USD 11.04 billion by 2030, and grow at a CAGR of 10.2% over the forecast period 2023-2030.
The Genome Editing Market size was estimated USD 6.4 billion in 2022 and is expected to reach USD 23.8 billion by 2030 at a CAGR of 17.9% during the forecast period of 2023-2030.
The Medical Imaging Market size was valued at USD 28.24 billion in 2022 and is expected to reach at USD 40.47 billion by 2030 and grow at a CAGR of 4.6% over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
